市場概況

The Global Virology Testing Market is poised for growth, with a projected increase from USD 12.48 億で 2022 米ドルへ 13.65 10億まで 2029, reflecting a modest compound annual growth rate (CAGR) の 1.2% during the period from 2023 に 2029. Virology testing encompasses a range of diagnostic techniques employed to identify viruses, including cell culture, antibody detection, antigen detection, nucleic acid detection, gene sequencing, and hemagglutination assays.

The COVID-19 pandemic has significantly propelled market growth, primarily driven by the escalating number of cases and the emergence of new viral strains. In response, companies have introduced diagnostic tests and kits, expanding their product portfolios to meet the growing demand. さらに, collaborations between industry players and governments have played a pivotal role in driving market expansion, fostering innovation, and enhancing testing capabilities.

The prevalence of viral diseases, coupled with the continuous emergence of new pathogens, is expected to be a key driver for market growth. さらに, the approval of new virology testing products by regulatory authorities will further contribute to market expansion, providing healthcare professionals with advanced tools for accurate and timely diagnosis.

しかし, it is important to note that stringent regulations governing virology testing may pose challenges for market players. Compliance with these regulations, including quality control measures and adherence to safety standards, requires significant investments and resources.

市場セグメンテーション

The market is segmented based on component, diagnostic technique, エンドユーザー, そして地理.

Segmentation by Component
楽器
Assay Kits and Consumables

Segmentation by Diagnostic Technique
Molecular Diagnostics Method – PCR-based methods, NGS-based methods
Immunoassay-based Method
Mass Spectroscopy-based Method
その他

エンドユーザーごとのセグメンテーション
Hospitals and Clinics
Diagnostic Laboratories
その他

地理によるセグメンテーション
北米 – アメリカ, カナダ, メキシコ
ヨーロッパ – イギリス, ドイツ, フランス, イタリア, スペイン, およびその他のヨーロッパ
アジア太平洋地域 – 中国, 日本, インド, オーストラリア, 韓国, およびその他のアジア太平洋地域
ラテンアメリカ – ブラジル, アルゼンチン, およびその他のラテンアメリカ諸国
中東とアフリカ – GCC, 南アフリカ, およびその他の中東およびアフリカ

The PCR-based molecular diagnostic methods segment is expected to gain a significant market share. PCR methods are widely used for pathogen detection, including viruses, and have improved diagnostic testing by reducing time and increasing accuracy. The COVID-19 pandemic has further boosted the segment’s growth, with RT-PCR being the preferred diagnostic method for COVID-19. Pharmaceutical and biotech companies are actively researching new molecules for COVID-19 treatment. Initiatives such as the launch of “”ViraGen”” in India and the development of a portable PCR molecular assay for monkeypox virus detection by Anitoa indicate the segment’s growth potential.

The regional market has grown due to advanced diagnostic methods, healthcare spending, favorable policies, and advanced laboratories. The United States’ R&D activities and viral infection cases, like influenza and HIV, have fueled demand for testing, leading to market growth. The virology testing market in the region is expected to continue growing.

競争環境

The virology testing market is fragmented and has many major players. Currently, a small number of these major players dominate the industry and hold significant market share. Some of the companies operating in this market include Abbott Laboratories, bioMerieux S.A., バイオ・ラッド・ラボラトリーズ株式会社, Cepheid Inc., DiaSorin S.p.A., F. ホフマン・ラ・ロシュAG, Fujirebio Diagnostics Inc., Hologic Inc., キアゲン N.V., シーメンス ヘルスニアーズ AG, サーモフィッシャーサイエンティフィック株式会社, Trinity Biotech plc, Vircell S.L., その他.

最近の業界の発展

QuantuMDx Group Limited announced the launch of its Q-POC SARS-CoV-2, Flu A/B & RSV Assay in May 2022. This respiratory panel test is compatible with the Q-POC platform, providing rapid point-of-care testing capabilities in clinical and non-clinical settings.

In January 2022, InTec introduced the AQ+ Covid-19 Ag Rapid Test, an ultra-sensitive SARS-CoV-2 Rapid Antigen Test for professional use. This test enables healthcare professionals or laypersons to quickly and conveniently detect Covid-19, contributing to the ongoing efforts against the pandemic.

このレポートを購入する理由?

Get a detailed picture of the Global Virology Testing Market
Identify segments/areas to invest in over the forecast period in the Global Virology Testing Market
競争環境を理解する, 市場の主要企業
Excel 形式でのシナリオ全体の分析を容易にするための市場予測
3ヶ月間の戦略コンサルティングとリサーチサポート
シングルユーザーライセンスに提供される印刷認証